20476 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Health bars and compositions for improving cardiovascular risk factors
#1802Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
#1803Therapy and Use of Compounds in Therapy
#1804Method of treating disorder related to high cholesterol concentration
#1805Treatment methods requiring phyto-ingredients
#1806Drug and food or drink for improving hyperglycemia
#1807Cationic Steroid Microbial Compositions and Methods of Use
#1808Cationic Steroid Antimicrobial Compositions and Methods of Use
#1809Cationic Steroid Antimicrobial Compositions and Methods of Use
#1810Cationic steroid antimicrobial compositions and methods of use
#1811Use of sex steroid function modulators to treat wounds and fibrotic disorders
#1812Ciclesonide and glycopyrronium combination
#1813Composition and method for issue repair and regeneration
#1814Strontium-based complexes, pharmaceutical compositions and dietetic products
#1815Composition with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods
#1816Dissolution of arterial cholesterol plaques by pharmacological preparation
#1817Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
#1818Method of preventive on-demand hormonal contraception
#1819HYPOCHOLESTEREMIC PREPARATIONS CONTAINING MIXTURES OF PHYTOSTENOL(ESTER)S AND CONJUGATED FATTY ACIDS, AND METHODS OF USING THE SAME
#1820Krill extracts for treatment of cardiovascular diseases
#1821Method for treatment or prevention of conditions caused by gram-positive bacteria
#1822Method for treating hyperglycemia
#1823Hydrothermically processed compositions containing phytosterols
#1824Oral contraception with trimegestone
#1825Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments
#1826Process
#1827Methods for reducing c-reactive protein
#1828Pulmonary surfactant formulations
#1829Agents and methods for enhancing bone formation
#1830Compositions containing micronized tanaproget prepared by wet granulation
#1831METHOD OF MAKING MEDICAMENT FOR TREATING ANEMIA
#1832Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
#1833Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof
#1834Cholesterol as an antibiotic for
#1835Method for restoration of gap junctional intercellular connection
#1836Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
#1837Nutritional supplement for lowering serum triglyceride and cholesterol levels
#1838Compositions of sugar-containing sterol solids dispersions
#1839medical composition
#1840Method for preventing ulceration or irritation of mucosa
#1841Bile preparations for gastrointestinal disorders
#1842Anti diarrhoea compositions
#1843Compositions for delivery of drug combinations
#1844Novel nutraceutical compositions comprising epigallocatechin gallate
#1845Methods and related compositions for the non-surgical removal of fat
#1846Use of physiologically active fatty acids
#1847Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
#1848Steroid compounds with anti-tumor activity
#1849Hypoglycemic agent
#1850Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
#1851Process to minimize loss through adhesion to equipment surfaces
#1852Hypocholesteremic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same
#1853Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
#1854Methods of treating injuries of the nervous system associated with hemorrhage
#1855Methods and related compositions for reduction of fat and skin tightening
#1856Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
#1857Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
#1858Methods and compositions for reducing toxicity of a pharmaceutical compound
#1859Treatment of fibrosis using FXR ligands
#1860Cholesterol-reducing agent made of dietary fibre and cholesterol-reducing substances
#1861Use of oculosurface selective glucocorticoid in the treatment of dry eye
#1862Mixtures or organic compounds for the treatment of airway diseases
#1863Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress
#1864Neuroprotective effect of solubilized UDCA in focal ischemic model
#1865Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers
#1866Method and compositions for treating pulmonary diseases
#1867Methods for inducing apolipoprotein e secretion
#1868Pulverulent phytosterol formulations
#1869Compositions and processes for water-dispersible phytosterols and phytostanols
#1870Treatment of lung diseases and pre-lung disease conditions
#1871Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
#1872Combination medicament
#1873Angiogenic compounds and uses thereof
#1874Ophthalmic compositions and methods for treating ophthalmic conditions
#1875Pharmaceutical compositions comprising calcitriol and a clobetasol propionate
#1876Monobactam compositions and methods of use thereof
#1877Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
#1878Methods for producing sterol esters of omega-3 fatty acids
#1879Methods and compositions for the non-surgical removal of fat
#1880Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium
#1881Management of breakthrough bleeding in extended hormonal contraceptive regimens
#1882Moisturizing foam containing lanolin
#1883Hypoglycemic agent
#1884Fortified confectionery products
#1885Anti-bacterial plant compositions
#1886Multi-vitamin and mineral nutritional supplements
#1887Structured lipid containing compositions and methods with health and nutrition promoting characteristics
#1888Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
#1889Medicinal composition containing an HMG-CoA reductase inhibitor
#1890Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
#1891Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium
#1892Stanol composition and the use thereof
#1893Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium
#1894Nitrate esters and their use for mitigating cellular damage
#1895Methods of using farnesoid x receptor (frx) agonists
#1896Naaladase inhibitors for treating huntington's disease
#1897Gastric acid secretion
#1898Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#1899Methods for producing sterol ester-rich compositions
#1900Medicaments for inhalation comprising an anticholinergic and a steroid
#1901Contraception method using competitive progesterone antagonists and novel compounds useful therein
#1902Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds
#1903Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
#1904Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists
#1905Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds
#1906Pharmaceutical composition for the treatment of itch
#1907Mixtures or organic compounds for the treatment of airway diseases
#1908Method of diagnosing fibromyalgia caused by small intestinal bacterial overgrowth
#1909Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
#1910Chemical structures that control metabolic elimination of aminosterols
#1911Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance
#1912Pharmaceutical composition Mix A to treat health conditions associated with elevated glucose levels
#1913Pharmaceutical composition Mix B to treat health conditions associated with elevated glucose levels
#1914Phytosterols for the prevention or treatment of non-alcoholic steatohepatitis
#1915extract as a vasodilator
#1916Dietary supplement formulations for teeth
#1917Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
#1918Multivitamin-mineral regimens for longevity and wellness
#1919Inhibitors of alpha-toxin